Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis
- 31 January 2004
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 92 (1) , 73-79
- https://doi.org/10.1016/s1081-1206(10)61713-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen–induced allergic rhinitis in an allergen-exposure unitJournal of Allergy and Clinical Immunology, 2002
- Complications of allergic rhinitisJournal of Allergy and Clinical Immunology, 2000
- Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- The Role of Leukotrienes in InflammationAnnals of Internal Medicine, 1994
- Allergic RhinitisNew England Journal of Medicine, 1991
- The Role of Leukotrienes in Allergic Rhinitis: A ReviewAmerican Review of Respiratory Disease, 1991
- Pathophysiology and treatment of seasonal allergic rhinitisRespiratory Medicine, 1990
- Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive childrenJournal of Allergy and Clinical Immunology, 1988
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical and Experimental Allergy, 1986
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984